Key result
This is a study protocol; therefore, no clinical results are available yet regarding the effect of enhanced external counterpulsation on heart rate variability in ischemic stroke patients.
Why the study?
Autonomic nervous system abnormalities following ischemic stroke affect recurrence and recovery, but literature exploring the effects of EECP on HRV in stroke patients is limited.
Does enhanced external counterpulsation improve heart rate variability in patients with first-ever ischemic stroke?
Does enhanced external counterpulsation improve heart rate variability in patients with first-ever ischemic stroke?
This study protocol outlines a single-arm trial to evaluate the feasibility and effect of enhanced external counterpulsation on heart rate variability and autonomic function in patients with ischemic stroke.
Answers are grounded in this paper and cite their sources.
EECP effects on HRV in ischemic stroke remain untested; this protocol leaves open whether it improves autonomic function or outcomes.
Background: Stroke is a prominent cause of mortality as well as disability globally. More than 40% of stroke survivors experience complications that last a lifetime. Following an ischemic stroke (IS), abnormalities in the autonomic nervous system (ANS) may influence the probability of another stroke and the healing process. Enhanced external counterpulsation (EECP) is a safe, effective, non-invasive treatment method that enhances blood circulation to the brain and manages ischemic cardiovascular and cerebrovascular diseases. There is a limited amount of literature exploring the effects of EECP on HRV specifically on stroke patients. Hence, the study aims to determine the impact of EECP on HRV in IS patients. Methods: This single arm pre and post intervention study recruits 35 out of 45 subjects. The intervention will be given 5 days/week/45 minutes a session for 35 sessions. Pre-and post-intervention outcome measures will be measured. After collecting the data, statistical analysis will be done. Conclusion: The application of EECP may be unlikely to cause any adverse effects in ischemic stroke patients, indicating that EECP may be a safe and effective treatment to improve hand grip strength and QOL in ischemic stroke patients. Trial registration: Clinical trials (CTRI): CTRI/2023/11/060112.
No takes yet. Share an insight, caveat, or question.
Janani et al. (2025) studied Ischemic stroke (n=35). Enhanced external counterpulsation (EECP) vs. Pre-intervention baseline was evaluated on Heart rate variability (HRV). This is a study protocol; therefore, no clinical results are available yet regarding the effect of enhanced external counterpulsation on heart rate variability in ischemic stroke patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: